A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...
المؤلفون الرئيسيون: | Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N |
---|---|
التنسيق: | Journal article |
منشور في: |
Wiley
2018
|
مواد مشابهة
-
No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
حسب: Andrea Hartner, وآخرون
منشور في: (2023-06-01) -
Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
حسب: Chan, M, وآخرون
منشور في: (2016) -
Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
حسب: Yeh, TL, وآخرون
منشور في: (2017) -
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
حسب: McNeill, L, وآخرون
منشور في: (2002) -
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
حسب: Mole, D, وآخرون
منشور في: (2003)